{
    "2014-01-14": [
        "Valeant, Mylan, and Actavis eye Pfizer's brand-new generics unit for buyout: Reuters #pharma $PFE $VRX $MYL $ACT",
        "Two Broad Morning Views $DDD $PFE $QQQ $SPY $STUDY",
        "Pfizerâ€™s new generics unit already has suitors, Reuters reports: Valeant, Actavis and Mylan $PFE $ACT $VRX $MYL"
    ]
}